Trialworks
Vendor:
First CVE: Jul 24, 2023 · Active for 2 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
6.1
Avg CVSS
Higher Avg CVSS than 21% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Trialworks over time
Volume of CVEsAvg CVSS Base Score
First CVE
Jul 24, 2023
2 years ago
Most Recent CVE
Jul 24, 2023
1,095 days ago
CVE Severity & Scoring
Trialworks1 CVEs
100%
All CVEs352,101 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None0 (0.0%)
Unknown0 (0.0%)
Required1 (100.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None1 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2023-37613MEDIUM A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the | Jul 24, 2023 | 6.1 | 18 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Trialworks
Top CWEs
Versions
| Version | CVE Count | Avg CVSS | Avg EPSS | KEV | Exploits |
|---|---|---|---|---|---|
| 11.4 | 1 | 6.1 | 0.4% | 0 | 0 |